Showing results (81-90 of 218) with videos related to

Sort By:
Pageof 22
Pharmaceutical Statistics|November 13, 2015
Teaching examples for the design of experiments: geographical sensitivity and the self-fulfilling prophecyDennis W Lendrem, B Clare Lendrem, Ruth Rowland-Jones, et al.
Clinical Medicine (London, England)|February 6, 2021
National Early Warning Score 2 (NEWS2) to identify inpatient COVID-19 deterioration: a retrospective analysisKenneth F Baker, Aidan T Hanrath, Ina Schim van der Loeff, et al.
BMC Rheumatology|July 19, 2021
BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort studyFiona Rayner, Amy E Anderson, Kenneth F Baker, et al.
Rheumatology Advances in Practice|August 22, 2019
Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label studyJohn D Isaacs, Abdelrazig Salih, Thomas Sheeran, et al.
RMD Open|February 17, 2024
Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritisPhilip M Brown, Amy E Anderson, Najib Naamane, et al.
Human Molecular Genetics|May 25, 2002
Promoter switch: a novel mechanism causing biallelic PEG1/MEST expression in invasive breast cancerInge Søkilde Pedersen, Peter Dervan, Alo McGoldrick, et al.
Annals of the Rheumatic Diseases|May 7, 2010
Profound invariant natural killer T-cell deficiency in inflammatory arthritisSusan J Tudhope, Alexei von Delwig, Jane Falconer, et al.
Arthritis and Rheumatism|February 2, 2008
Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomesAlice R Lorenzi, Alexandra M Clarke, Tom Wooldridge, et al.
Digestive Diseases and Sciences|August 21, 2020
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical TrialsRemo Panaccione, John D Isaacs, Lea Ann Chen, et al.
Annals of the Rheumatic Diseases|June 2, 2016
High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohortMeghna Jani, John D Isaacs, Ann W Morgan, et al.
Pageof 22